Cargando…

Measuring direct non-medical burden among patients with advanced non-small cell lung cancer in China: is there a difference in health status?

OBJECTIVE: This study was conducted to estimate the direct non-medical cost of advanced non-small cell lung cancer (NSCLC) patients and explore whether its associated factors vary by health status. METHODS: Data were obtained from 13 centers in five provinces for patients with advanced NSCLC in Chin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xia, Yu, Chen, Yingyao, Chen, Jia, Gan, Yuying, Su, Chunxia, Zhang, Haibo, Long, Enwu, Yan, Fei, Yang, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Public Health
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192575/ https://www.ncbi.nlm.nih.gov/pubmed/37213608 http://dx.doi.org/10.3389/fpubh.2023.1090623

Ejemplares similares

Measuring the indirect cost associated with advanced non-small cell lung cancer: a nationwide cross-sectional study in China
por: Yang, Yi, et al.
Publicado: (2022)

A Study of Patient Preferences for the Treatment of Non–small Cell Lung Cancer in Western China: A Discrete-Choice Experiment
por: Liu, Fei, et al.
Publicado: (2021)

Economic Evaluation of First-Line Camrelizumab for Advanced Non-small-cell Lung Cancer in China
por: Xiang, Guiyuan, et al.
Publicado: (2021)

Inequalities in access to community-based diabetes examination and its impact on healthcare utilization among middle-aged and older adults with diabetes in China
por: Deng, Qingwen, et al.
Publicado: (2022)

Assessment of Health-Related Quality of Life Using EuroQoL-5 Dimension in Populations With Prediabetes, Diabetes, and Normal Glycemic Levels in Southwest China
por: Long, Enwu, et al.
Publicado: (2021)

Disparities of obesity and non-communicable disease burden between the Tibetan Plateau and developed megacities in China
por: Peng, Wen, et al.
Publicado: (2023)

Cohort profile: the Lanxi Cohort study on obesity and obesity-related non-communicable diseases in China
por: Wei, Chen, et al.
Publicado: (2019)

Time trends in cardiovascular disease mortality attributable to non-optimal temperatures in China: An age-period-cohort analysis using the Global Burden of Disease Study 2019
por: Wei, Jiehua, et al.
Publicado: (2023)

Investigation of 3-year inpatient TB cases in Zunyi, China: Increased TB burden but improved bacteriological diagnosis
por: Chen, Ling, et al.
Publicado: (2022)

Impact of socioeconomic status on cancer staging, survival in non-small cell lung cancer
por: Yang, Xianghui, et al.
Publicado: (2022)

Global, regional, and national burden and attributable risk factors of neurological disorders: The Global Burden of Disease study 1990–2019
por: Ding, Chenyu, et al.
Publicado: (2022)

The economic burden of malaria inpatients and its determinants during China's elimination stage
por: Chen, Fangfei, et al.
Publicado: (2022)

The impact of medical financial assistance on healthcare expenses and the medical financial burden: Evidence from rural China
por: Chen, Yucheng, et al.
Publicado: (2023)

Age-Related Disease Burden in China, 1997–2017: Findings From the Global Burden of Disease Study
por: Hu, Dan, et al.
Publicado: (2021)

Impacts of the zero mark-up policy on hospitalization expenses of T2DM and cholecystolithiasis inpatients in SC province, western China: an interrupted time series analysis
por: Guo, Xirui, et al.
Publicado: (2023)

Burden of non-accidental mortality attributable to ambient temperatures: a time series study in a high plateau area of southwest China
por: Deng, Changyu, et al.
Publicado: (2019)

Tislelizumab plus chemotherapy is more cost-effective than chemotherapy alone as first-line therapy for advanced non-squamous non-small cell lung cancer
por: Liang, Xueyan, et al.
Publicado: (2023)

How does diabetic peripheral neuropathy impact patients' burden of illness and the economy? A retrospective study in Beijing, China
por: Pan, Qi, et al.
Publicado: (2023)

Cost-effectiveness of ensartinib, crizotinib, ceritinib, alectinib, brigatinib and lorlatinib in patients with anaplastic lymphoma kinase-positive non-small cell lung cancer in China
por: Luo, Xia, et al.
Publicado: (2022)

The burden of liver cirrhosis in mortality: Results from the global burden of disease study
por: Ye, Fei, et al.
Publicado: (2022)

Growing Burden of Non-Communicable Diseases in the Emerging Health Markets: The Case of BRICS
por: Jakovljevic, Mihajlo B., et al.
Publicado: (2015)

Economic Burden of Major Diseases in China in 2013
por: Song, Xianyan, et al.
Publicado: (2021)

Economic evaluation of toripalimab combined with chemotherapy in the treatment of non-small cell lung cancer
por: Wang, Hao, et al.
Publicado: (2023)

Cost-Effectiveness Analysis of Triple Combination Preparations in the Treatment of Moderate-to-Severe Chronic Obstructive Pulmonary Disease
por: Zhou, Yikang, et al.
Publicado: (2021)

Global, regional, and national burden of digestive diseases: findings from the global burden of disease study 2019
por: Wang, Fang, et al.
Publicado: (2023)

The Burden of COPD in China and Its Provinces: Findings From the Global Burden of Disease Study 2019
por: Yin, Peng, et al.
Publicado: (2022)

Trends in economic burden of type 2 diabetes in China: Based on longitudinal claim data
por: Liu, Xinyi, et al.
Publicado: (2023)

Estimation of Relative Risk of Mortality and Economic Burden Attributable to High Temperature in Wuhan, China
por: Chen, Si, et al.
Publicado: (2022)

Burdens of non-communicable disease attributable to metabolic risk factors in Australia, 1990–2019: joinpoint regression analysis of the Global Burden of Disease Study
por: Kibret, Kelemu Tilahun, et al.
Publicado: (2023)

Evaluation of Unified Healthcare Efficiency in China: A Meta-Frontier Non-radial Directional Distance Function Analysis During 2009–2019
por: Guo, Baojie, et al.
Publicado: (2022)

A Comparative Study on the Health Status and Behavioral Lifestyle of Centenarians and Non-centenarians in Zhejiang Province, China—A Cross-Sectional Study
por: Rong, Chao, et al.
Publicado: (2019)

Noise exposure assessment of non-coal mining workers in four provinces of China
por: Wang, Xin, et al.
Publicado: (2023)

Coupling the effects of extreme temperature and air pollution on non-accidental mortality in Rencheng, China
por: Yu, Daozheng, et al.
Publicado: (2023)

A comparative examination of the health status of earthquake-affected and non-earthquake-affected adolescents in Yushu
por: Zhao, Fangjie, et al.
Publicado: (2022)

Economic Burden and Influencing Factors of Acute Gastroenteritis in China: A Population-Based Face to Face Survey in 2018
por: Huo, Yue, et al.
Publicado: (2022)

Trends in Disease Burden Attributable to Tobacco in China, 1990–2017: Findings From the Global Burden of Disease Study 2017
por: Wen, Haoyu, et al.
Publicado: (2020)

DALY trend and predictive analysis of COPD in China and its provinces: Findings from the global burden of disease study
por: Zhai, Mimi, et al.
Publicado: (2022)

Group-based intervention to improve developmental status among children age 6–18 months in rural Shanxi province, China: a study protocol for a cluster randomised controlled trial
por: Xu, Mengxue, et al.
Publicado: (2020)

The know-do gap in quality of health for chronic non-communicable diseases in rural China
por: Meng, Sha, et al.
Publicado: (2022)

Time trends in the burden of stroke and subtypes attributable to PM2.5 in China from 1990 to 2019
por: Chen, Huijing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hrplulvh1pjdekt6i4ac31hm4i